An increase in fatty acid oxidation, a suppression/delay on the de novo liver lipogenesis, gastric emptying, and appetite are other important GLP-1 RA effects, especially in patients with type 2 diabetes T2DM and obesity [42,43]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.